Indogulf Cropsciences
- Market cap
- ₹ 369 Cr.
- P/E
- 9.7x
- P/B
- 0.83x
- 52-week range
- 49.46 – 108.29
- ROE
- 11%
- ROCE
- 12%
- Dividend yield
- 0%
- Debt / equity
- 0.4
- Sector
- Fertilizers & Agrochemicals
- Industry
- Pesticides & Agrochemicals
- Listed on
- NSE, BSE
About
Indogulf Cropsciences Limited is an India-based company. The Company is engaged in the business of manufacturing crop protection products, plant nutrients and biologicals in India. It also exports its products to over 34 countries. It manufactures and markets a range of products in all types of available formulations, such as water dispersible granules (WDG), suspension concentrate (SC), capsule suspension (CS), ultra-low volume (ULV), emulsion in water (EW), soluble granule (SG), flowable suspension (FS) and others, which can be in powder, granules and liquid form to customers. The Company’s products are categorized into three divisions, such as crop protection, biostimulant, and plant supplements. Its crop protection products include Baton, Dawn-7000, Dhamaal-50, and others. Its biostimulant products include Empire, Indo Breeza, Indo Apache, Indo Biogold, and Indo Apache 1025. Its plant supplement includes Indogulf B20, Picaso Gold, Sona Shree Gold, Root-O-Max Gold, and others.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pesticides & Agrochemicals: 33 companies →Indogulf Cropsciences against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)9.7 against a typical 23.3: cheaper than most peers (1st = cheapest).2nd of 33
- Sales growth−11% against a typical −4.5% from a year earlier.22nd of 31
- Profit growth−37.7% against a typical +15.2% from a year earlier.22nd of 25
- Share price, 3 months−23.5% against a typical −15.5%.27th of 32
- Size₹ 369.1 Cr. market value against a typical ₹ 883.3 Cr. (1st = largest).22nd of 31
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A- by ICRA- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| ICRA | [ICRA]A- | Stable | 31 Oct 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 31 Oct 2025 | ▲ Upgrade4 notches | [ICRA]BB+ ISSUER NOT COOPERATING → [ICRA]A- | — | ICRA | ₹ 217 Cr. | |
| 5 Sep 2025 | ▼ Downgrade | [ICRA]BB+ ISSUER NOT COOPERATING | — | ICRA | ₹ 197 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 12 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 28 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 11 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 12 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 13 Aug 2025 | Financial Results | To consider and approve the financial results of the Company for the quarter ended Jun 30, 2025 |
| 24 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 132 | 233 | 99 | 126 | 189 | 248 | 116 | 151 | 169 |
| Expenses | 119 | 126 | 205 | 89 | 105 | 179 | 216 | 104 | 130 | 159 |
| Operating Profit | 20 | 6 | 27 | 10 | 21 | 10 | 32 | 12 | 20 | 10 |
| OPM % | 14.6% | 4.5% | 11.8% | 10.1% | 16.5% | 5.2% | 12.9% | 10.1% | 13.5% | 5.7% |
| Other Income | 3 | 2 | 1 | 1 | 2 | 1 | 2 | 3 | 2 | 1 |
| Interest | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 4 | 4 | 5 |
| Depreciation | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 4 | 3 |
| Profit before tax | 18 | 2 | 23 | 5 | 15 | 5 | 27 | 7 | 14 | 3 |
| Tax % | 27.6% | 34.3% | 26.7% | 20.6% | 35.5% | 16.8% | 23.7% | 47.7% | 16.7% | 22.8% |
| Net Profit | 13 | 1 | 17 | 4 | 10 | 4 | 21 | 4 | 12 | 2 |
| EPS in Rs | 5.5 | 0.28 | 3.42 | 0.75 | 2.01 | 0.79 | 3.27 | 0.61 | 1.84 | 0.38 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 10%
- 3 Years
- 9%
- TTM
- 6%
- 10 Years
- —
- 5 Years
- 12%
- 3 Years
- 21%
- TTM
- 14%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 13%
- 3 Years
- 12%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Indogulf Cropsciences | ₹ 59.40 | ₹ 369 Cr. | 9.7x | 0.8x | 11% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Om Prakash Aggarwal
- Executive Chairman of the Board
- Manoj Gupta
- Chief Financial Officer
- Sakshi Jain
- Compliance Officer, Company Secretary
- Sanjay Aggarwal
- Managing Director, Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.